Market Overview

30 Stocks Moving in Monday's Pre-Market Session

Share:
30 Stocks Moving in Monday's Pre-Market Session

Gainers

  • China Pharma Holdings, Inc. (NASDAQ: CPHI) shares rose 93% to $1.10 in pre-market trading after falling around 10% on Friday.
  • Applied DNA Sciences, Inc. (NASDAQ: APDN) shares rose 70.4% to $6.80 in pre-market trading after the company issued updates on COVID-19 collaboration with Takis Biotech.
  • Forty Seven, Inc. (NASDAQ: FTSV) rose 61% to $93.40 in pre-market trading after Gilead announced plans to acquire the company for $95.50 per share in cash.
  • Dynatronics Corporation (NASDAQ: DYNT) rose 48.4% to $2.85 in pre-market trading after surging over 59% on Friday.
  • Karyopharm Therapeutics Inc. (NASDAQ: KPTI) rose 43.8% to $23.50 in pre-market trading after the company disclosed that its Phase 3 BOSTON study meets primary endpoint with significant increase in progression-free survival in patients with multiple myeloma following one to three prior lines of therapy.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) rose 40.7% to $1.52 in pre-market trading after declining around 38% on Friday.
  • Co-Diagnostics, Inc. (NASDAQ: CODX) shares rose 36.1% to $18.00 in pre-market trading after the company announced it will provide COVID-19 tests to US CLIA labs.
  • Trillium Therapeutics Inc. (NASDAQ: TRIL) rose 31.9% to $6.66 in pre-market trading after climbing around 63% on Friday.
  • iBio, Inc. (NYSE: IBIO) rose 26.1% to $3.09 in pre-market trading after jumping around 183% on Friday. iBio disclosed a $100 million mixed securities offering.
  • Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose 25.4% to $0.33 in pre-market trading after gaining 25% on Friday.
  • Dyadic International, Inc. (NASDAQ: DYAI) shares rose 23.1% to $7.25 in pre-market trading.
  • OpGen, Inc. (NASDAQ: OPGN) rose 22.1% to $4.14 in pre-market trading after surging more than 66% on Friday.
  • Altimmune, Inc. (NASDAQ: ALT) rose 17.6% to $4.35 in pre-market trading. Altimmune climbed more than 110% on Friday after the company reported completion of first development milestone toward a single-dose intranasal coronavirus vaccine.
  • AIM ImmunoTech Inc. (NYSE: AIM) shares rose 16.1% to $2.38 in pre-market trading after surging around 20% on Friday.
  • Alpha Pro Tech, Ltd. (NYSE: APT) rose 13.1% to $23.76 in pre-market trading after falling around 17% on Friday.
  • First Majestic Silver Corp. (NYSE: AG) rose 8.8% to $8.20 in pre-market trading after declining 9% on Friday.
  • Transocean Ltd. (NYSE: RIG) rose 8.4% to $3.63 in pre-market trading after jumping about 11% on Friday.
  • DRDGOLD Limited (NYSE: DRD) rose 7.9% to $6.58 in pre-market trading after falling over 8% on Friday.
  • Yamana Gold Inc. (NYSE: AUY) rose 7.1% to $4.09 in pre-market trading after falling around 6% on Friday.
  • Twitter, Inc. (NYSE: TWTR) rose 7% to $35.50 in pre-market trading. Elliott Management is seeking to replace Twitter’s CEO Jack Dorsey.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Borr Drilling Limited (NYSE: BORR) shares fell 18.5% to $1.96 in pre-market trading after declining over 10% on Friday.
  • Zomedica Pharmaceuticals Corp. (NYSE: ZOM) shares fell 11.4% to $0.1950 in pre-market trading after dropping 12% on Friday.
  • Carnival Corporation & Plc (NYSE: CUK) fell 8.6% to $29.09 in pre-market trading.
  • Carnival Corporation & Plc (NYSE: CCL) shares fell 8.3% to $30.70 in pre-market trading after rising 5% on Friday.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) fell 7.8% to $2.00 in pre-market trading.
  • The Royal Bank of Scotland Group plc (NYSE: RBS) shares fell 5.8% to $4.36 in pre-market trading.
  • Tata Motors Limited (NYSE: TTM) fell 5.7% to $8.65 in pre-market trading after declining over 5% on Friday.
  • Barclays PLC (NYSE: BCS) fell 5.7% to $7.26 in pre-market trading.
  • Frontline Ltd. (NYSE: FRO) fell 5.3% to $7.76 in pre-market trading after gaining 7% on Friday.
  • InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 3.6% to $5.93 in pre-market trading after dipping over 18% on Friday.
 

Related Articles (AIM + AG)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Pre-Market Outlook Markets Movers Trading Ideas